You are here
Home 🌿 Medical Cannabis News 🌿 Aurora Cannabis completes sale of cannabis oils to German pharmacies 🌿Aurora Cannabis completes sale of cannabis oils to German pharmacies
Warning message
The subscription service is currently unavailable. Please try again later.In another move to expand internationally, Alberta-based Aurora Cannabis Inc. (NYSE: ACB; TSX: ACB; Frankfurt: 21P) today began selling Pedanios 5/1 branded cannabis oils to pharmacies in Germany.
The move follows completion of several regulatory hurdles from both the German and Canadian sides. Following that announcement, Aurora’s stock was up just over 3% this morning.
Aurora’s Chief Global Business Development Officer Neil Belot commented on the company’s strategy behind moving into the German market with oil extracts:
Having established early mover advantage in selling cannabis oils in Germany, we are positioned to extend our market leadership and accelerate growth of European operations. As our global production capacity continues to ramp up, we are able to allocate more product from our EU GMP certified cultivation facilities to this higher margin market that continues to be undersupplied.
The company already supplies dried flower products in Germany through Aurora Deutschland, which was recently rebranded from its former name Pedanios.
While operations continue to expand to meet increased consumer demand in Canada after recreational legalization arrived last year, major licensed producers such as Aurora have also focused on growing globally.
Latin America has consistently played a major role in those international plans, with Aurora acquiring both the Uruguay-based ICC Labs in September and then Mexican cannabis distributor Farmacias Magistrales SA at the end of 2018.
That international strategy has included trading on the US-based New York Stock Exchange (NYSE) for increased market presence and additional fund-raising opportunities. Aurora applied to trade on the NYSE last year and began trading on the market officially in late October.
On the Canadian side, last week Aurora completed the acquisition of British Columbia-based Whistler Medical Marijuana Corporation, which was one of the very first companies to become licensed by Health Canada to cultivate medical cannabis.
Aurora will now assist Whistler in the construction and expansion of a second cultivation facility located in Pemberton, with a full operational capacity of 5,000 kg per year expected to arrive by the end of summer in 2019.
Aside from acquisitions and construction projects, Aurora is preparing to open what will be the most highly visible retail cannabis store in the country with a spot in the world-renowned West Edmonton Mall.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.